Niels Kjær Stampe

Dr. Niels Kjær Stampe

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2024 in European Heart Journal
Verified
Journal Article
Open access
PDF file
CPChristian Paludan-Müller
Christian Paludan-Müller
OVOliver B Vad
Oliver B Vad
NSNiels Kjær Stampe
Niels Kjær Stampe
SDSøren Z Diederichsen
Søren Z Diederichsen
LALaura Andreasen
Laura Andreasen
MOMorten Olesen
Morten Olesen
Background and Aims: Patients with atrial fibrillation (AF) are at increased risks of cardiovascular diseases and mortality, but risks according to age at diagnosis have not been reported. This study investigated age-specific risks of outcomes among patients with AF and the background population. Methods: This nationwide population-based cohort study included patients with AF and controls without outcomes by the application of exposure density matching on the basis of sex, year of birth, and index date. The absolute risks and hazard rates were stratified by age groups and assessed using competing risk survival analyses and Cox regression models, respectively. The expected differences in residual life years among participants were estimated. Results: The study included 216 579 AF patients from year 2000 to 2020 and 866 316 controls. The mean follow-up time was 7.9 years. Comparing AF patients with matched controls, the hazard ratios among individuals ≤50 years was 8.90 [95% confidence interval (CI), 7.17–11.0] for cardiomyopathy, 8.64 (95% CI, 7.74–9.64) for heart failure, 2.18 (95% CI, 1.89–2.52) for ischaemic stroke, and 2.74 (95% CI, 2.53–2.96) for mortality. The expected average loss of life years among individuals ≤50 years was 9.2 years (95% CI, 9.0–9.3) years. The estimates decreased with older age. Conclusions: The findings show that earlier diagnosis of AF is associated with a higher hazard ratio of subsequent myocardial disease and shorter life expectancy. Further studies are needed to determine causality and whether AF could be used as a risk marker among particularly younger patients.

18 February 2020 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
MJMia Ravn Jacobsen
Mia Ravn Jacobsen
RJReza Jabbari
Reza Jabbari
CGCharlotte Glinge
Charlotte Glinge
NSNiels Kjær Stampe
Niels Kjær Stampe
JBJawad Haider Butt
Jawad Haider Butt
TEThomas Engstrøm
Thomas Engstrøm
Background: Potassium disturbances per se increase the risk of ventricular fibrillation ( VF ). Whether potassium disturbances in the acute phase of ST ‐segment–elevation myocardial infarction ( STEMI ) are associated with VF before primary percutaneous coronary intervention ( PPCI ) is uncertain. Methods and Results: All consecutive STEMI patients were identified in the Eastern Danish Heart Registry from 1999 to 2016. Comorbidities and medication use were assessed from Danish nationwide registries. Potassium levels were collected immediately before PPCI start. Multivariate logistic models were performed to determine the association between potassium and VF . The main analysis included 8624 STEMI patients of whom 822 (9.5%) had VF before PPCI . Compared with 6693 (77.6%) patients with normokalemia (3.5–5.0 mmol/L), 1797 (20.8%) patients with hypokalemia (5.0 mmol/L) were older with more comorbidities. After adjustment, patients with hypokalemia and hyperkalemia had a higher risk of VF before PPCI (odds ratio 1.90, 95% CI 1.57–2.30, P <0.001) and (odds ratio 3.36, 95% CI 1.95–5.77, P <0.001) compared with normokalemia, respectively. Since the association may reflect a post‐resuscitation phenomenon, a sensitivity analysis was performed including 7929 STEMI patients without VF before PPCI of whom 127 (1.6%) had VF during PPCI . Compared with normokalemia, patients with hypokalemia had a significant association with VF during PPCI (odds ratio 1.68, 95% CI 1.01–2.77, P =0.045) after adjustment. Conclusions: Hypokalemia and hyperkalemia are associated with increased risk of VF before PPCI during STEMI . For hypokalemia, the association may be independent of the measurement of potassium before or after VF .

28 July 2020 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
NSNiels Kjær Stampe
Niels Kjær Stampe
CJCamilla Bang Jespersen
Camilla Bang Jespersen
CGCharlotte Glinge
Charlotte Glinge
HBHenning Bundgaard
Henning Bundgaard
JTJacob Tfelt-Hansen
Jacob Tfelt-Hansen
BWBo Gregers Winkel
Bo Gregers Winkel

15 December 2022 in EP Europace
Verified
Journal Article
Open access
PDF file
ATAnna F Thomsen
Anna F Thomsen
CJChristian Jøns
Christian Jøns
RJReza Jabbari
Reza Jabbari
MJMia R Jacobsen
Mia R Jacobsen
NSNiels Kjær Stampe
Niels Kjær Stampe
PJPeter Karl Jacobsen
Peter Karl Jacobsen
Emerging data show that complete revascularization (CR) reduces cardiovascular death and recurrent myocardial infarction in ST-segment elevation myocardial infarction (STEMI). However, the influence of revascularization status on development of arrhythmia in the long-term post-STEMI phase is poorly described. We hypothesized that incomplete revascularization (ICR) compared with CR in STEMI is associated with an increased long-term risk of new-onset arrhythmia. Patients with STEMI treated with primary percutaneous coronary intervention (PPCI) at Copenhagen University Hospital, Rigshospitalet, Denmark, with CR or ICR were identified via the Eastern Danish Heart registry from 2009 to 2016. Using unique Danish administrative registries, the outcomes were assessed. The primary outcome was new-onset arrhythmia defined as a composite of atrial fibrillation/flutter (AF), sinoatrial block, advanced second- or third-degree atrioventricular block, ventricular tachycardia/fibrillation (VT), or cardiac arrest (CA), with presentation >7 days post-PPCI. Secondary outcomes were the components of the primary outcome and all-cause mortality. A total of 5103 patients (median age: 62.0 years; 76% men) were included, of whom 4009 (79%) and 1094 (21%) patients underwent CR and ICR, respectively. Compared with CR, ICR was associated with a higher risk of new-onset arrhythmia [hazard ratio (HR), 1.33; 95% confidence interval (CI), 1.07–1.66; P = 0.01], AF (HR, 1.29; 95% CI, 1.00–1.66; P = 0.05), a combined outcome of VT and CA (HR, 1.77; 95% CI, 1.10–2.84; P = 0.02) and all-cause mortality (HR, 1.27; 95% CI, 1.05–1.53; P = 0.01). All HRs adjusted. Among patients with STEMI, ICR was associated with an increased long-term risk of new-onset arrhythmia and all-cause mortality compared with CR. Long-term risk of new-onset arrhythmia in ST-segment elevation myocardial infarction according to revascularization status. Created with BioRender.com.

23 November 2017 in EP Europace
Verified
Journal Article
Closed access
PDF file
NSNiels Kjær Stampe
Niels Kjær Stampe
CGCharlotte Glinge
Charlotte Glinge
RJReza Jabbari
Reza Jabbari
TBThea Bjune
Thea Bjune
BRBjarke Risgaard
Bjarke Risgaard
BWBo Gregers Winkel
Bo Gregers Winkel
Febrile seizure (FS) is a common disorder affecting 2–5% of children up to 5 years of age. The aim of this study was to determine whether FS in early childhood are over-represented in young adults dying from sudden cardiac death (SCD). We included all deaths (n = 4595) nationwide and through review of all death certificates, we identified 245 SCD in Danes aged 1–30 years in 2000–09. Through the usage of nationwide registries, we identified all persons admitted with first FS among SCD cases (14/245; 5.7%) and in the corresponding living Danish population (71 027/2 369 785; 3.0%) and also in victims of transport accidents (26/917; 2.8%). The frequency of FS among SCD cases was significantly increased by an odds ratio of 1.96 [95% confidence interval (CI) 1.14–3.36; P = 0.021] compared with the living Danish population and with an odds ratio of 2.08 (95% CI 1.07–4.04; P = 0.046) compared with transport accident victims. SCD cases did not differ statistically in birth year (P = 0.272), age at SCD (P = 0.667) or prior medical conditions, except for epilepsy (P < 0.001), when comparing SCD with and without prior FS. The most common cause of death in autopsied SCD cases with FS was sudden arrhythmic death syndrome (5/8; 62.5%). In conclusion, this study demonstrates a significantly two-fold increase in the frequency of FS prior to death in young SCD cases compared with the two control groups, suggesting that FS could potentially contribute in a risk stratification model for SCD and warrant further studies.

4 April 2024 in Resuscitation
Verified
Journal Article
Closed access
NSNiels Kjær Stampe
Niels Kjær Stampe
CGCharlotte Glinge
Charlotte Glinge
BRBrian Schou Rasmussen
Brian Schou Rasmussen
PBPriya Bhardwaj
Priya Bhardwaj
KLKristian Linnet
Kristian Linnet
BWBo Gregers Winkel
Bo Gregers Winkel